FAP and familial pancreatic carcinoma: Nonetheless, depletion of FAP+ CAFs in mice with pancreatic cancer enabled the antitumor efficacy of immune checkpoint blockade, namely anti-CTLA4 and anti-PD-L1 (CD274) antibodies (Box 2) (Feig et al., 2013).